Investments in progress
We are currently investing in one or more companies that passed our rigorous selection process. Please login or create an account to learn more and co-invest with us.
Our portfolio companies
Our portfolio companies are currently developing diagnostics for early detection of cancer via blood sample, saving lives in emergency care and surgery through software innovations, developing personalised treatments of severe diseases, and much more.
MedFilm offers a subscription service for animated information videos about surgical procedures. With the videos, surgery clinics can easily provide patients with information before surgery.
1928 Diagnostics is fighting against the global threat of resistant bacteria by offering software for the quick and effective diagnose of bacterial infections. The software is offered as a software-as-a-service and in combination with hardware already used in hospitals it provided detailed information regarding bacteria and their resistance profiles.
Likvor offers a CE-certified system helping healthcare personnel to diagnose normal pressure hydrocephalus (NPH) which is a very under diagnosed condition with dementia-like symptoms.
Former portfolio companies that have reached new heights through acquisition or listing, and continue to thrive under new ownership. These companies continue to make a lasting impact in their respective industries.
Inhalation Science’s technology is used by leading players in the chemical and pharmaceutical sectors to study how airborne particles affect the human body.Read more
Lipigon develops orphan drugs for illnesses due to disorders in how the body handles fat. The company’s major program, Lipsense, focuses on the illness, HoFH, where there is, today, no sufficient treatment.Read more